SN50 peptide is a highly potent inhibitor of NF-kB. SN50 peptide consists of the hydrohobic region of K-FGF Kaposi’s fibroblast growth factor (NF-KB) fused to the NLS sequence of NF-kB p50. The SN50 peptide enters cells and inhibits the translocation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) into the nucleus. It is also a radiosensitizer used to prepare prostate cells for radiotherapy with DOTA or other radioligands.
NF-kB Inhibitor SN50 - Translocation Inhibitor - Specifications
- Peptide sequence: H-AAVALLPAVLLALLAPVQRKRQKLMP-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in plastic vial
- MW (average): 2781.54
- Application(s): Nuclear medicine
- Condition(s)/Topic(s): Cancer
- Standard Delivery Time: 2-5 days
- CAS: 213546-53-3
Are you interested in other peptides or conjugation to a protein, nucleic acid or lipid? Choose your sequence, amount and purity with our
Custom Peptide Synthesis services.
JPT’s Oncology Peptides
One focus of JPT’s product development is oncology. Therefore, we offer a huge variety of TAA peptide, peptide pools and microarrays, as well as <DOTA peptides and radio sensitizers. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Have a look at our Peptide Tools to Study Cancer.
Benefits of JPT’s Peptides- All peptides are made in Germany
- Bulk orders or custom peptide synthesis upon request
- Provision of freeze-dried aliquots for enhanced stability
- Proven track record
- Need the conjugated or modified peptide? Contact us!
